Emerald
UK-based healthtech company reimagining preventive care. Combining diagnostics, AI, and GP insights helps people take control of their health before symptoms appear. The platform’s AI engine analyses data from blood tests, wearables, and lifestyle inputs, identifying early warning signs and suggesting actionable steps —an integrated approach rarely found in existing NHS and private pathways.
London, UK
Total raised
€1.7M
€1,749,305
Funding rounds
2
Investors
13
distinct backers
Active since
2025-05
latest 2026-01
Funding by year
EUR raised per year · 2026 YTDSignals
High confidenceRaise-next likelihood17
base rate 24% for Pre-Seed
- ▼ Raised very recently
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood9
base rate 12% (2+ rounds)
- ▼ Young (<3y)
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-01-29 | Pre-Seed | €1.0M | Angel Investors,Boost Capital Partners,Granatus Ventures,Innovate UK,Mark Fountain | View deal → |
| 2025-05-14 | Other | €743k | Harry Glorikian,Jane Austin,Johann Huber,Mart Abramov,Mike Benchimol,Nikolay Tretiakov+2 more | View deal → |